212 related articles for article (PubMed ID: 24528617)
1. Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome.
Ice DS; Shapiro TA; Gnall EM; Kowey PR
Am J Cardiol; 2014 Mar; 113(5):888-96. PubMed ID: 24528617
[TBL] [Abstract][Full Text] [Related]
2. Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
Capodanno D; Angiolillo DJ
Circ Cardiovasc Interv; 2014 Feb; 7(1):113-24. PubMed ID: 24550531
[No Abstract] [Full Text] [Related]
3. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
Rubboli A; Agewall S; Huber K; Lip GY
Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
[TBL] [Abstract][Full Text] [Related]
4. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
Cairns JA; McMurtry MS
Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
[TBL] [Abstract][Full Text] [Related]
5. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
Helft G; Gilard M; Le Feuvre C; Zaman AG
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
[TBL] [Abstract][Full Text] [Related]
6. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen KJ; Cuisset T; Kirchhof P; Marín F;
Thromb Haemost; 2010 Jan; 103(1):13-28. PubMed ID: 20062939
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Kar S; Bhatt DL
Coron Artery Dis; 2012 Sep; 23(6):380-90. PubMed ID: 22728913
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel hydrogen sulphate for atrial fibrillation.
Garg N; Rajpurohit N; Flaker G
Expert Opin Pharmacother; 2011 Aug; 12(11):1781-7. PubMed ID: 21663525
[TBL] [Abstract][Full Text] [Related]
9. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
10. Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?
Asencio LA; Huang JJ; Alpert JS
Am J Med; 2014 Jul; 127(7):579-85. PubMed ID: 24608021
[TBL] [Abstract][Full Text] [Related]
11. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
Depta JP; Cannon CP; Fonarow GC; Zhao X; Peacock WF; Bhatt DL;
Am J Cardiol; 2009 Nov; 104(9):1171-8. PubMed ID: 19840557
[TBL] [Abstract][Full Text] [Related]
12. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention.
Pareek M; Bhatt DL; Ten Berg JM; Kristensen SD; Grove EL
Expert Opin Pharmacother; 2017 Jun; 18(9):875-883. PubMed ID: 28489475
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
Lenchus JD
Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
[TBL] [Abstract][Full Text] [Related]
15. Investigational factor Xa inhibitors for thrombosis and acute coronary syndromes.
Romualdi E; Ageno W
Expert Opin Investig Drugs; 2011 Apr; 20(4):495-505. PubMed ID: 21385107
[TBL] [Abstract][Full Text] [Related]
16. Novel oral anticoagulants in secondary prevention of stroke.
Diener HC; Easton JD; Hankey GJ; Hart RG
Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
[TBL] [Abstract][Full Text] [Related]
18. Triple therapy in hospitalized patients: facts and controversies.
Srour JF; Smetana GW
J Hosp Med; 2011 Nov; 6(9):537-45. PubMed ID: 21374797
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic regimens in patients with indication for long-term anticoagulation undergoing coronary interventions-systematic analysis, review of literature, and implications on management.
Deshmukh A; Hilleman DE; Del Core M; Nair CK
Am J Ther; 2013; 20(6):654-63. PubMed ID: 21519218
[TBL] [Abstract][Full Text] [Related]
20. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
Aguilar MI; Kuo RS; Freeman WD
Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
